anticancer agents (RND Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Nameanticancer agents (RND Pharmaceuticals)

Drug Alias NameRND-102RND-101RND-103

ClassificationSmall molecules

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSilamed Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSilamed Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A